InsidersTradesSigma
Follow the ARTRYA LIMITED share price and the full insider trade history of the company, a listed issuer based in Australia. Shares are quoted on AU AU, under the oversight of ASX. Market capitalisation: €1bn. The latest transaction was reported on 18 June 2026 (Purchase). Among the most active insiders: Bernie Ridgeway. Every trade is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
ARTRYA LIMITED is a company listed on the XASX, focused on developing technological solutions for cardiac health. It aims to improve clinical outcomes through digital innovation.